Christopher Van Tuyl
Chief Legal Officer at Immunovant · 7 reported transactions in 1 company · latest trade Oct 7, 2026
Their trades
Sold | Oct 7, 2026 | Oct 7, 2026 close $32.04 → Oct 29, 2026 close $29.64. S&P 500 −0.6% over the same days. | ||
Sold | Sep 23, 2026 | Sep 23, 2026 close $34.54 → Oct 29, 2026 close $29.64. S&P 500 +0.6% over the same days. | ||
Sold | Jun 26, 2026 | Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days. | ||
Sold | Jun 26, 2026 | Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days. | ||
Sold | Dec 18, 2025 | Dec 18, 2025 close $26.18 → Oct 29, 2026 close $29.64. S&P 500 +14.2% over the same days. | ||
Sold | Dec 18, 2025 | Dec 18, 2025 close $26.18 → Oct 29, 2026 close $29.64. S&P 500 +14.2% over the same days. |
SoldImmunovant
$42.5K
Oct 7, 2026 close $32.04 → Oct 29, 2026 close $29.64. S&P 500 −0.6% over the same days.
SoldImmunovant
$103.5K
Sep 23, 2026 close $34.54 → Oct 29, 2026 close $29.64. S&P 500 +0.6% over the same days.
SoldImmunovant
$110.7K
Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days.
SoldImmunovant
$572.2K
Jun 26, 2026 close $38.85 → Oct 29, 2026 close $29.64. S&P 500 +5.9% over the same days.
SoldImmunovant
$62.5K
Dec 18, 2025 close $26.18 → Oct 29, 2026 close $29.64. S&P 500 +14.2% over the same days.
SoldImmunovant
$228.4K
Dec 18, 2025 close $26.18 → Oct 29, 2026 close $29.64. S&P 500 +14.2% over the same days.